Overview of Locally Advanced/Metastatic Urothelial Carcinoma

July 7, 2022

Video

Vinit Makkar, MD, provides a brief overview of locally advanced/metastatic urothelial carcinoma (la/mUC), available first-line (1L) and first-line maintenance (1LM) treatment options, and unmet needs in the field.

Now Viewing

EP: 1.Overview of Locally Advanced/Metastatic Urothelial Carcinoma

EP: 2.Scope and Methods of the PARADIGM Study and Expert Commentary on Treatment Decision-Making

EP: 3.Perspectives on First-Line Treatment Decision-Making for la/mUC: Results of The Targeted Literature Search and Qualitative Interviews

EP: 4.A Cross-Sectional Survey Reveals Physicians’ Treatment Patterns in First-Line and Maintenance Therapy for la/mUC

EP: 5.Key Factors Associated with First-Line and Maintenance Therapy Prescription Frequency

EP: 6.Key Takeaways from the PARADIGM Study

EP: 7.Recap: US Physician PARADIGM Study Informs Decision-Making in Locally Advanced/Metastatic Urothelial Carcinoma

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!